Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GDC-0449 in Basal Cell Nevus Syndrome
NCT00957229Phase 2Completed
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Start
- Aug 2009
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in Basal cell nevus syndrome (BCNS), sponsored by UCSF Benioff Children's Hospital Oakland. Started Aug 2009; status: completed.
02
Drugs
vismodegib
03
Conditions
Basal cell nevus syndrome (BCNS)
Beyond the preview
Go deeper on NCT00957229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957229.